Deep Dive
1. Native USDC liquidity growth
Overview: Posts on November 19 reported native USDC on Injective rose from about $15 million to $32.8 million, tied to a dYdX migration and broader Cosmos stablecoin flows (on X). More stablecoin liquidity can support activity on Injective, but does not necessarily mean direct buying of INJ. INJ trading volume was up 17.36% in 24h, consistent with increased activity.
What it means: The liquidity growth may have encouraged interest in INJ, but the available data cannot establish it as the sole cause of the price gain.
2. No clear secondary driver
Overview: INJ rose while Bitcoin fell 1.27% and the total crypto market declined about 1%, so broad market beta does not explain the outperformance. No coin-specific derivatives data or confirmed secondary catalyst was available; the broader backdrop remains pressured by ETF outflows and rate concerns (Decrypt).
What it means: The move appears relatively INJ specific, but its durability is not confirmed.
3. Near-term Market Outlook
Overview: INJ is down 4.69% over 7 days and 20.53% over 30 days, and remains below its 7-day average of $7.23. If it holds above $7.18, the next technical level is $7.65; a break below $6.58 could expose the 200-day average near $5.88. The reported Veyra mainnet upgrade is scheduled for November 24 (post on X).
What it means: Near-term momentum is improving, but the broader trend has not turned up.
Watch for: Whether INJ clears $7.18 and holds, and whether the November 24 upgrade proceeds as reported.
Conclusion
Market Outlook: Neutral, with a short-term rebound. Reported USDC growth and stronger trading activity may help explain INJ’s relative strength, but the wider downtrend and resistance overhead remain risks.
Key watch: Can INJ hold above $7.18 into the reported November 24 Veyra upgrade?